Michael Shusterman, MD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Colon cancer
- Rectal cancer
- Anal cancer
My Specialties
- Chemotherapy
- Targeted therapy
- Immunotherapy
Get to Know Me
I’m a gastrointestinal (GI) medical oncologist at Memorial Sloan Kettering Cancer Center (MSK). I’m an expert in diagnosing and treating cancers of the digestive system. This includes:
- Colorectal cancer and anal cancer
- Pancreatic cancer
- Esophageal cancer and stomach (gastric) cancer
- Liver cancer, bile duct cancer (cholangiocarcinoma), and gallbladder cancer
I also treat GI-related neuroendocrine tumors and cancers of unknown origin (when doctors can’t find where the cancer started).
I care for patients at MSK Nassau on Long Island. I work closely with a skilled team of MSK surgeons, radiation oncologists, radiologists, and pathologists. Together, we evaluate your case to develop the most effective treatment plan for your specific situation.
Working at MSK Nassau allows me to bring MSK’s world-class resources directly to patients on Long Island. This includes access to clinical trials (research studies that test promising new treatments) close to home.
To treat GI cancers, I use a range of therapies tailored to each person’s cancer diagnosis. These include:
- Chemotherapy (medicines that kill cancer cells or stop them from growing)
- Targeted therapy (drugs that attack specific changes in cancer cells)
- Immunotherapy (drugs that help your immune system fight cancer)
- New clinical trial treatments
My grandparents were doctors who taught me the importance of compassion and care that focuses on the patient. I chose to become a GI oncologist because I wanted to help patients and their families through the challenges of a cancer diagnosis. I also wanted to give them access to new and promising treatments.
Cancer-related medical terms, test results, and treatments can often feel like a foreign language. My goal during visits is to make sure you leave feeling informed, supported, and confident in your treatment plan. I aim to explain your diagnosis and treatment options clearly.
We will talk about how your diagnosis affects your daily life and what matters most to you. Together, we will build a treatment plan that reflects your personal values, treats your cancer as effectively as possible, and protects your quality of life.
Cancer care is changing quickly, with new therapies giving patients more options and hope. But having more choices can also make decisions feel overwhelming and confusing. As your oncologist, I stay up to date on the latest GI cancer research. I will help you understand what new discoveries may mean for you and whether a new treatment or clinical trial may be a good option.
Beyond patient care, I engage in GI cancer research, and I teach and mentor doctors who are training to become cancer specialists. I also study ways to improve cancer care and help patients live better during and after treatment.
Outside of work, I love spending time with my family and enjoy science fiction and fantasy.
I'm a gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist, which is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers. We also treat GI stromal tumors and neuroendocrine tumors.
- Associated Attending Physician
Conditions I Treat
- Colon cancer
- Rectal cancer
- Anal cancer
- Appendiceal (appendix) cancer and conditions
- Pancreatic cancer
- Bile duct cancer (cholangiocarcinoma)
- Esophageal cancers and conditions
- Gallbladder cancer
- Gastrointestinal neuroendocrine tumors
- Liver cancer and conditions
- Secondary liver cancer (liver metastases)
- Stomach (gastric) cancer
- Cancer of unknown primary origin (CUP)
My Specialties
- Chemotherapy
- Targeted therapy
- Immunotherapy
- Clinical trials
Education
- MD, Albert Einstein College of Medicine
Residencies
- Internal Medicine, Montefiore Medical Center (Moses/Weiler)
Fellowships
- Hematology and Medical Oncology, NewYork-Presbyterian/Weill Cornell Medical Center
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Awards and Honors
- Hematology Oncology Fellowship Faculty Educator of the Year Award, NYU Grossman Long Island School of Medicine (2022)
- Annual Meeting Merit Award, American Society of Clinical Oncology (2020)
- Outstanding House Officer in Internal Medicine Award, Montefiore Medical Center (2017)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, HMO
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO
This is a dual payer plan, which means 2 health insurance companies share this plan. MSK providers are out-of-network with UnitedHealthcare.
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
This plan is in-network at our New York sites only.
In Network Coverage Type
HMO, PPO
Starting January 1, 2027, MSK will no longer be in-network for Healthfirst Medicare plans. This applies to all Healthfirst Medicare Advantage plans and dual-eligible Medicare Advantage special needs plans.
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
PPO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
EPO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
EPO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
PPO, HMO
Your plan may not cover visits to our New York sites. Please call the number on the back of your insurance card to see what your health plan covers.
In Network Coverage Type
State Government
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO (City Employee Health Plans Gold and Gold Care Only)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, EPO
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
State Government
This plan is in-network at our New York sites only.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
State Government
Learn more about the insurance plans that participate with MSK.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
Health plans can change at any time. Call the number on the back of your insurance card to see what your plan covers. Make sure it covers the MSK location where you’ll get care.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
- Peng C, Saffo S, Oberstein PE, Shusterman M, Thomas C, Becker DJ, Berlin JD, Leichman LP, Boursi B, Nagar AB, Yu S. (2024). Omission of 5-Fluorouracil Bolus from Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study. J Natl Compr Canc Netw. 5:1-7. doi.org/10.6004/jnccn.2024.7029
- Bulancea S, Grewal US, Wronska M, Vadehra D, Hornstein N, Brown TJ, Shusterman M. (2026). Optimizing Systemic Therapy in Advanced Gastrointestinal Malignancies: Strategies to Minimize Toxicity and Maximize Tolerability. Clinical Colorectal Cancer. doi.org/10.1016/j.clcc.2026.05.004
- Ng K, Ou, FS, Zemlg T, Jackson NA, Kalyan A, Devoe C, Shusterman M, Vijayvergia N, Wu CS, Cohen SA, Pulsipher S, Shergill A, Watson Y, Kleiber B, Lee M, Kohn CG, Thalappillil JS, Schwartz LH, Zuckerman D, Hollis BW, O’Reilly EM, Meyerhardt JA. (2026). Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703). JAMA. doi.org/10.1001/jama.2026.9350
Visit PubMed for a full listing of Dr. Shusterman’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.